Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient ...

Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

MARIA, a 42-year-old teacher with an energetic spirit, had always been an active woman. However, one morning after a long ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

There are no direct trials comparing these different forms of treatment. Each has shown reasonable efficacy as detailed in the literature below. Conventional management of acute DVT is based upon ...

Unique treatment options are emerging for the management of this patient population. We are excited to evaluate a new device for patients diagnosed with pulmonary embolism." said David M.

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Patients with DVT, PE, or DVT and PE had higher annualized ... Early detection and appropriate treatment of this high-risk population have the potential for both clinical and economic benefits.

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.